• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床遗传学检测在主动脉疾病管理中的作用。

Role of Clinical Genetic Testing in the Management of Aortopathies.

机构信息

Cardiology Division and Cardiovascular Genetics Program, Massachusetts General Hospital, Boston, MA, USA.

出版信息

Curr Cardiol Rep. 2021 Jan 21;23(2):10. doi: 10.1007/s11886-020-01435-6.

DOI:10.1007/s11886-020-01435-6
PMID:33475873
Abstract

PURPOSE OF REVIEW

Thoracic aortic aneurysms (TAA) have a strong heritable basis, and identification of a genetic etiology has important implications for patients with TAA and their relatives. This review provides an overview of Mendelian causes of TAA, discusses important considerations for genetic testing, and summarizes the impact a genetic diagnosis may have on a patient's medical care.

RECENT FINDINGS

Thoracic aortic disease may be non-syndromic or seen as part of a genetic syndrome, such as Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome. Expanded access to genetic testing has revealed the wide and overlapping phenotypic spectrum of these conditions, highlighting the need for genetic testing to establish an accurate diagnosis. Important aspects of genetic evaluation include thorough phenotyping through family history and physical examination, selection of an appropriate genetic test driven by the patient's phenotype, and careful interpretation of genetic test results. Improved understanding of the natural history of these conditions has led to tailored management recommendations, including gene-based recommendations for prophylactic surgical repair. Identification of a genetic etiology allows for careful monitoring of disease progression, informs the timing of prophylactic surgical repair, and facilitates the identification of other at-risk relatives through cascade genetic testing.

摘要

目的综述

胸主动脉瘤(TAA)具有很强的遗传性基础,确定其遗传病因对 TAA 患者及其亲属具有重要意义。本文综述了 TAA 的孟德尔病因,讨论了基因检测的重要注意事项,并总结了基因诊断可能对患者医疗护理产生的影响。

最近的发现

胸主动脉疾病可能是非综合征性的,也可能是马凡综合征、Loeys-Dietz 综合征或血管型 Ehlers-Danlos 综合征等遗传综合征的一部分。基因检测的广泛应用揭示了这些疾病广泛且重叠的表型谱,强调了基因检测在确立准确诊断中的必要性。基因评估的重要方面包括通过家族史和体格检查进行彻底的表型分析、根据患者的表型选择适当的基因检测、以及仔细解释基因检测结果。对这些疾病自然史的认识不断提高,导致了针对性的管理建议,包括基于基因的预防性手术修复建议。确定遗传病因可以帮助患者密切监测疾病进展,告知预防性手术修复的时机,并通过级联基因检测识别其他高危亲属。

相似文献

1
Role of Clinical Genetic Testing in the Management of Aortopathies.临床遗传学检测在主动脉疾病管理中的作用。
Curr Cardiol Rep. 2021 Jan 21;23(2):10. doi: 10.1007/s11886-020-01435-6.
2
[Familial thoracic aortic aneurysms and dissections (FTAAD)].[家族性胸主动脉瘤和夹层(FTAAD)]
Kardiol Pol. 2011;69(12):1291-7.
3
The Expanding Clinical Spectrum of Extracardiovascular and Cardiovascular Manifestations of Heritable Thoracic Aortic Aneurysm and Dissection.遗传性胸主动脉瘤和夹层的心血管和心血管外临床表现的不断扩大的临床谱。
Can J Cardiol. 2016 Jan;32(1):86-99. doi: 10.1016/j.cjca.2015.11.007. Epub 2015 Nov 14.
4
Aortopathies: etiologies, genetics, differential diagnosis, prognosis and management.主动脉病:病因、遗传学、鉴别诊断、预后和管理。
Am J Med. 2013 Aug;126(8):670-8. doi: 10.1016/j.amjmed.2013.01.029. Epub 2013 Jun 22.
5
Genetic Risk for Aortic Aneurysm in Adolescent Idiopathic Scoliosis.青少年特发性脊柱侧凸患者主动脉瘤的遗传风险
J Bone Joint Surg Am. 2015 Sep 2;97(17):1411-7. doi: 10.2106/JBJS.O.00290.
6
Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.遗传性主动脉瘤及相关疾病的遗传学触发的主动脉瘤和相关条件的 GenTAC 登记处:心血管结局。
J Am Coll Cardiol. 2022 May 31;79(21):2069-2081. doi: 10.1016/j.jacc.2022.03.367.
7
Canadian Cardiovascular Society position statement on the management of thoracic aortic disease.加拿大心血管学会关于胸主动脉疾病管理的立场声明。
Can J Cardiol. 2014 Jun;30(6):577-89. doi: 10.1016/j.cjca.2014.02.018. Epub 2014 Feb 28.
8
The Loeys-Dietz syndrome: an update for the clinician.洛伊氏迪茨综合征:临床医生的最新资讯。
Curr Opin Cardiol. 2010 Nov;25(6):546-51. doi: 10.1097/HCO.0b013e32833f0220.
9
The Genetics of Aortopathies in Clinical Cardiology.临床心脏病学中的主动脉病变遗传学
Clin Med Insights Cardiol. 2017 May 30;11:1179546817709787. doi: 10.1177/1179546817709787. eCollection 2017.
10
A Review of the Genetics of Intracranial Berry Aneurysms and Implications for Genetic Counseling.颅内浆果样动脉瘤的遗传学综述及其对遗传咨询的意义
J Genet Couns. 2017 Feb;26(1):21-31. doi: 10.1007/s10897-016-0029-8. Epub 2016 Oct 14.

引用本文的文献

1
Non-canonical splice variants in thoracic aortic dissection cases and Marfan syndrome with negative genetic testing.胸主动脉夹层病例和基因检测呈阴性的马凡综合征中的非经典剪接变体。
NPJ Genom Med. 2025 Mar 21;10(1):25. doi: 10.1038/s41525-025-00472-w.
2
Growth Rate Assessed by Vascular Deformation Mapping Predicts Type B Aortic Dissection in Marfan Syndrome.通过血管变形映射评估的生长速率可预测马凡综合征中的B型主动脉夹层。
J Am Heart Assoc. 2025 Mar 18;14(6):e039179. doi: 10.1161/JAHA.124.039179. Epub 2025 Feb 26.
3
Identification of Genetic Variants Associated with Hereditary Thoracic Aortic Diseases (HTADs) Using Next Generation Sequencing (NGS) Technology and Genotype-Phenotype Correlations.

本文引用的文献

1
Familial Clustering of Aortic Size, Aneurysms, and Dissections in the Community.社区中主动脉大小、动脉瘤和夹层的家族聚集性。
Circulation. 2020 Sep 8;142(10):920-928. doi: 10.1161/CIRCULATIONAHA.120.045990. Epub 2020 Jun 25.
2
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.马凡综合征中应用厄贝沙坦(AIMS):一项双盲、安慰剂对照随机试验。
Lancet. 2019 Dec 21;394(10216):2263-2270. doi: 10.1016/S0140-6736(19)32518-8. Epub 2019 Dec 10.
3
Genetics of syndromic and nonsyndromic aortopathies.综合征型和非综合征型主动脉病变的遗传学。
使用下一代测序(NGS)技术和基因型-表型相关性鉴定与遗传性胸主动脉疾病(HTADs)相关的遗传变异。
Int J Mol Sci. 2024 Oct 17;25(20):11173. doi: 10.3390/ijms252011173.
4
Mental Health Care for Children with Heart Disease and Their Families: Practical Approaches and Considerations for the Pediatric and Pediatric Cardiology Clinician.为患有心脏病的儿童及其家庭提供的心理健康护理:儿科和儿科心脏病学临床医生的实用方法与注意事项
Pediatr Cardiol. 2025 Apr;46(4):757-768. doi: 10.1007/s00246-024-03518-5. Epub 2024 May 16.
5
Heritable thoracic aortic disease: a literature review on genetic aortopathies and current surgical management.遗传性胸主动脉疾病:关于遗传性主动脉病变及当前外科治疗的文献综述
Gen Thorac Cardiovasc Surg. 2024 May;72(5):293-304. doi: 10.1007/s11748-024-02017-x. Epub 2024 Mar 14.
6
Hereditary Thoracic Aortic Diseases.遗传性胸主动脉疾病
Diagnostics (Basel). 2024 Jan 4;14(1):112. doi: 10.3390/diagnostics14010112.
7
Early clinical outcomes and molecular smooth muscle cell phenotyping using a prophylactic aortic arch replacement strategy in Loeys-Dietz syndrome.在洛伊斯-迪茨综合征中采用预防性主动脉弓置换策略的早期临床结果及分子平滑肌细胞表型分析
J Thorac Cardiovasc Surg. 2023 Nov;166(5):e332-e376. doi: 10.1016/j.jtcvs.2023.07.023. Epub 2023 Jul 25.
8
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南:美国心脏协会/美国心脏病学会联合委员会临床实践指南的报告。
J Thorac Cardiovasc Surg. 2023 Nov;166(5):e182-e331. doi: 10.1016/j.jtcvs.2023.04.023. Epub 2023 Jun 28.
9
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Dec 13;80(24):e223-e393. doi: 10.1016/j.jacc.2022.08.004. Epub 2022 Nov 2.
10
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106. Epub 2022 Nov 2.
Curr Opin Pediatr. 2019 Dec;31(6):694-701. doi: 10.1097/MOP.0000000000000836.
4
Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD).遗传性非综合征性胸主动脉瘤和夹层(nshTAAD)法国样本中遗传多样性和致病性变异作为严重程度的可能预测因子。
Genet Med. 2019 Sep;21(9):2015-2024. doi: 10.1038/s41436-019-0444-y. Epub 2019 Feb 11.
5
Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients.对 199 例患者中与遗传性主动脉病和结缔组织相关疾病相关的 32 个基因进行下一代测序。
Genet Med. 2019 Aug;21(8):1832-1841. doi: 10.1038/s41436-019-0435-z. Epub 2019 Jan 24.
6
pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium.致病性变异:蒙塔尔奇诺主动脉联盟的胸主动脉疾病和相关并发症风险。
J Med Genet. 2019 Apr;56(4):252-260. doi: 10.1136/jmedgenet-2018-105583. Epub 2019 Jan 19.
7
Marfan syndrome: improved clinical history results in expanded natural history.马凡综合征:改良临床病史可导致扩展的自然病史。
Genet Med. 2019 Aug;21(8):1683-1690. doi: 10.1038/s41436-018-0399-4. Epub 2018 Dec 21.
8
Frequency of de novo variants and parental mosaicism in vascular Ehlers-Danlos syndrome.血管型 Ehlers-Danlos 综合征中新生变异和父母镶嵌现象的频率。
Genet Med. 2019 Jul;21(7):1568-1575. doi: 10.1038/s41436-018-0356-2. Epub 2018 Nov 26.
9
Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection.遗传性胸主动脉瘤和夹层的基因临床有效性。
J Am Coll Cardiol. 2018 Aug 7;72(6):605-615. doi: 10.1016/j.jacc.2018.04.089.
10
MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants.MYLK 致病变体与主动脉疾病的表现、妊娠风险,以及致病错义变异体的特征。
Genet Med. 2019 Jan;21(1):144-151. doi: 10.1038/s41436-018-0038-0. Epub 2018 Jun 20.